Prescribing of continuous glucose monitoring sensors by all CCGs

Why it matters: Continuous glucose monitoring devices (CGM) can significantly reduce the need for people with diabetes to conduct finger-prick testing.

NICE guidance for Type 1 diabetes in adults, Type 2 diabetes in adults and Type 1 and Type 2 diabetes in children and young people were all updated in March 2022. The updates include recommendations that all patients with type 1 diabetes should be offered a choice of real-time continuous glucose monitoring (rtCGM) or intermittently scanned continuous glucose monitoring (isCGM) and that adults with type 2 diabetes on multiple daily insulin injections should be offered GM where they meet specific clinical criteria.

Description: Prescribing of continuous glucose monitoring sensors per 1000 patients


Tagged as: Standard, Diabetes (or browse all measures)

CCGs are ordered by mean percentile over the past six months. Each chart shows the results for the individual CCG, plus deciles across all CCGs in the NHS in England.

View measure for NHS England combined →

Fetching data...

Do you need help with your analysis? Don't forget to check the FAQ page, and if you have questions.